Aroa Biosurgery Ltd (arx) Logo

Aroa Biosurgery Ltd (ARX)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News
Announcements

ARX ASX Chart

Snapshot

Aroa Biosurgery Limited (ARX) is a soft-tissue regeneration company that develops, manufactures and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) +38.91%
vs ASX 200 (1yr) +0.09%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 808 of 2,337
Sector Rank 49 of 241

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies AVR / PGC / SDI
EPS $0.011
DPS $0.00
Book Value Per Share $0.239

Broker Consensus

ARX is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Mangere Auckland New Zealand 2022
Website www.aroa.com
Registry Automic Group
Auditor BDO Auckland
Date Listed 24 Jul 2020

Upcoming Calendar (Forecasted)

Date Event
19/08/2026 AGM
24/11/2026 Report (Interim)
25/05/2027 Report (Prelim)
29/06/2027 Report (Annual)

Former Company Names

  • Aroa Biosurgery Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

ARX directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
26/06/26 John Diddams Sell +200,000 $0.629 ($125,789) On-market trade
23/07/25 Philip McCaw Expiry 81,925 $0.59 $48,335 Options expired
23/07/25 John Pinion II Expiry 245,775 $0.59 $145,007 Options expired
23/07/25 James (Jim) McLean Expiry 52,400 $0.59 $30,916 Options expired
23/07/25 Brian Ward Expiry 3,132,525 $0.59 $1,848,189 Options expired
16/06/25 Brian Ward Expiry 591,768 $0.50 $295,884 Options expired
06/06/25 John Diddams Sell +160,000 $0.484 ($77,474) On-market trade
30/09/24 Catherine Mohr Buy +436,364 $0.375 $163,453 On-market trade
22/08/24 Darla Hutton Issued 140,110 $1.00 $140,110 Issue of securities
22/08/24 Brian Ward Issued 961,255 $0.44 $422,952 Issue of securities
27/03/24 Steven (Steve) Engle Issued 633,225 $0.098 $61,992 Exercise of options
27/03/24 Steven (Steve) Engle Exercise 633,225 $0.098 $61,992 Exercise of options
16/02/24 Philip McCaw Buy +326,000 $0.575 $187,450 On-market trade
06/09/23 James (Jim) McLean Buy +50,000 $0.75 $37,500 Exercise of options
06/09/23 James (Jim) McLean Exercise 50,000 $0.75 $37,500 Exercise of options
11/08/23 Catherine Mohr Issued 210,686 $0.88 $185,403 Issue of options
31/03/23 Steven (Steve) Engle Issued 172,620 $1.05 $181,251 Issue of options
31/03/23 John Pinion II Issued 172,620 $1.05 $181,251 Issue of options
31/03/23 James (Jim) McLean Issued 258,929 $1.05 $271,875 Issue of options
31/03/23 Brian Ward Issued 2,575,483 $1.05 $2,704,257 Issue of options
31/03/23 Philip McCaw Issued 172,620 $1.05 $181,251 Issue of options
31/03/23 John Diddams Issued 172,620 $1.05 $181,251 Issue of options
14/12/22 John Diddams Issued 20,452 $1.09 $22,292 Issue of options
14/12/22 John Diddams Buy +165,000 $0.107 $17,732 Exercise of options
14/12/22 John Diddams Exercise 165,000 $0.107 $17,732 Exercise of options
30/08/22 John Diddams Buy +50,000 $0.806 $40,286 On-market trade
12/04/22 James (Jim) McLean Buy +102,400 $0.75 $76,800 Exercise of options
12/04/22 James (Jim) McLean Exercise 102,400 $0.75 $76,800 Exercise of options
12/04/22 Philip McCaw Buy +81,925 $0.75 $61,443 Exercise of options
12/04/22 Philip McCaw Exercise 81,925 $0.75 $61,443 Exercise of options
25/03/22 John Diddams Buy +165,000 $0.107 $17,732 Exercise of options
25/03/22 John Diddams Exercise 165,000 $0.107 $17,732 Exercise of options
19/08/21 James (Jim) McLean Buy +102,400 $0.75 $76,800 Exercise of options
19/08/21 James (Jim) McLean Exercise 102,400 $0.75 $76,800 Exercise of options
06/08/21 Philip McCaw Transfer 2,864,879 $1.15 $3,298,621 Off-market transfer
11/06/21 Philip McCaw Buy +81,925 $0.75 $61,443 Exercise of options
11/06/21 Philip McCaw Exercise 81,925 $0.75 $61,443 Exercise of options
22/02/21 John Diddams Sell +200,000 $1.19 ($238,680) On-market trade
09/12/20 John Diddams Buy +165,000 $0.107 $17,737 Exercise of options
09/12/20 John Diddams Exercise 165,000 $0.107 $17,737 Exercise of options
Show All

Director Interests

The current holdings of ARX directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
John Diddams 26/06/2026 N/A 832,550 193,072 N/A
Paul Shearer 31/10/2025 500,000 N/A N/A N/A
Brian Ward 23/07/2025 N/A 33,125,800 1,357,873 N/A
James (Jim) McLean 23/07/2025 2,827,108 N/A 258,929 N/A
Philip McCaw 23/07/2025 N/A 20,077,154 172,620 N/A
Darla Hutton 30/03/2025 140,110 N/A N/A N/A
Catherine Mohr 30/03/2025 N/A 436,364 210,686 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on May 16, 2025.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
J P Morgan Nominees Australia Pty Limited 54,177,509 15.71%
HSBC Custody Nominees (Australia) Limited 40,003,479 11.60%
Brian Ward, Tracey Ward & Thomas Ward <Arawai No2 A/C> 33,125,800 9.60%
Phil Mccaw <Mcsyth Capital Invest A/C> 19,597,251 5.68%
Citicorp Nominees Pty Limited 13,535,396 3.92%
Richard Abbott <Jester 002 Investment A/C> 13,043,020 3.78%
BNP Paribas Noms (Nz) Ltd 12,626,147 3.66%
Mirrabooka Investments Limited 11,426,177 3.31%
Aspire Nz Seed Fund Ltd 10,421,614 3.02%
K One W One (No 3) Ltd 5,882,550 1.71%
Custodial Services Limited <Beneficiaries Holding A/C> 5,766,819 1.67%
Bnp Paribas Noms Pty Ltd 5,199,275 1.51%
HSBC Custody Nominees (Australia) Limited A/C 2 4,567,671 1.32%
Sharon Bryant <Ot Investment A/C> 4,372,267 1.27%
John Anthony Dell 4,348,864 1.26%
Barnaby May 3,272,775 0.95%
Christopher David Astley Milne 3,248,022 0.94%
K One W One Ltd 3,041,226 0.88%
Sharesies Australia Nominee Pty Limited 2,890,667 0.84%
James Mclean 2,827,108 0.83%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
FirstCape Group Limited 16/05/2025 30,421,199 8.82
State Street Australia Ltd 16/05/2025 17,288,432 5.01
Phil McCaw 16/05/2025 20,077,154 5.82
Brian Ward 16/05/2025 33,125,800 9.91
Acorn Capital Limited 27/05/2026 29,842,804 8.63

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
27-05-26 Acorn Capital Limited 3,651,020 7.59 8.63
09-10-25 Acorn Capital Limited 3,700,678 6.52 7.59

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2025 $0.58 30 June
2024 $0.598 28 June
2023 $0.925 30 June
2022 $0.66 30 June
2021 $1.12 30 June
2018 $0.30 29 June
2017 $0.515 28 June
2016 $0.45 28 June
2015 $0.001 30 June
2014 $0.003 30 June
ARX Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.